CINV: Chemotherapy-Induced Nausea and Vomiting – Antiemetics


The MOQC Chemotherapy-Induced Nausea and Vomiting (CINV) – Antiemetics initiative aims to improve the quality of care provided to patients receiving chemotherapy throughout Michigan. The initiative supports practices in conducting baseline assessments, implementing quality improvement processes, and providing resources for provider and patient education.

Practice Benefits

  • Access to current patient and provider resources for CINV symptom management
  • Available performance data in the area of CINV guideline adherence
  • Opportunities to improve value-based reimbursement (VBR) targets
  • Sharing best practices and processes

ASCO & NCCN recommend that high emetic chemotherapy regimens receive 4-drug prophylaxis.

Antiemetics Team

Emily Mackler, PharmD, BCOP
Director, POEM

Ashley Bowen, MS, RD
Senior Project Manager



Word Document

Contact Information

For more information, please contact